Glomerulonephritis, Poststreptococcal Treatment & Management
- Author: Duvuru Geetha, MD, MRCP; Chief Editor: Vecihi Batuman, MD, FACP, FASN more...
Medical Care
Symptomatic therapy is recommended for patients with acute poststreptococcal glomerulonephritis (APSGN), and it should be based on the clinical severity of the illness. The major goal is to control edema and blood pressure.
- During the acute phase of the disease, restrict salt and water.
- If significant edema or hypertension develops, administer diuretics.
- Loop diuretics increase urinary output and consequently improve cardiovascular congestion and hypertension.
- For hypertension not controlled by diuretics, usually calcium channel blockers or angiotensin-converting enzyme inhibitors are useful. For malignant hypertension, intravenous nitroprusside or other parenteral agents are used.
- Indications for dialysis include life-threatening hyperkalemia and clinical manifestations of uremia.
- Restricting physical activity is appropriate in the first few days of the illness but is unnecessary once the patient feels well.
- Steroids, immunosuppressive agents, and plasmapheresis are not generally indicated.
- A renal biopsy is indicated for patients with rapidly progressive renal failure. If the biopsy findings show evidence of crescentic glomerulonephritis with more than 30% of the glomeruli involved, a short course of intravenous pulse steroid therapy is recommended (500 mg to 1 g/1.73 m2 of methylprednisone qd for 3-5 d). However, no controlled clinical trials have evaluated such therapy.
- Long-term treatment with steroids or immunosuppressives is not recommended.
- Specific therapy for streptococcal infection is an important part of the therapeutic regimen.
- Treat patients, family members, and any close personal contacts who are infected.
- Throat cultures should be performed on all these individuals. Treat with oral penicillin G (250 mg qid for 7-10 d) or with erythromycin (250 mg qid for 7-10 d) for patients allergic to penicillin.
- This helps prevent nephritis in carriers and helps prevent the spread of nephritogenic strains to others.
- Patients with skin infections must practice good personal hygiene. This is essential.
- During epidemics, recommend that high-risk individuals, including close contacts and family members, receive empirical prophylactic treatment.
Surgical Care
Surgical care is not indicated.
Consultations
- Nutritionist or dietitian
- Nephrologist
Diet
- Low-salt diet - Two grams of sodium per day
- Fluid restriction - One liter per day
Activity
- Restricting physical activity is appropriate in the first few days of the illness but is not necessary once the patient feels well.
Zegers RH, Weigl A, Steptoe A. The death of Wolfgang Amadeus Mozart: an epidemiologic perspective. Ann Intern Med. Aug 18 2009;151(4):274-8, W96-7. [Medline].
Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. Oct 2008;19(10):1855-64. [Medline].
Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. Apr 2008;20(2):157-62. [Medline].
Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. Jan 2009;174(1):115-22. [Medline]. [Full Text].
Oda T, Tamura K, Yoshizawa N, et al. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant. Jul 2008;23(7):2254-9. [Medline].
Bakr A, Mahmoud LA, Al-Chenawi F, et al. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr Nephrol. Mar 2007;22(3):376-9. [Medline].
Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. Jul 2008;23(7):1101-6. [Medline].
Parra G, Rodriguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. Aug 1998;54(2):509-17. [Medline].
Taskesen M, Taskesen T, Katar S, et al. Elevated plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis. Tohoku J Exp Med. Apr 2009;217(4):295-8. [Medline]. [Full Text].
Sorger K, Gessler U, Hubner FK, et al. Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol. Mar 1982;17(3):114-28. [Medline].
Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. Sep 2005;68(3):1120-9. [Medline].
Dedeoglu IO, Springate JE, Waz WR, et al. Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis. Clin Nephrol. Nov 1996;46(5):302-5. [Medline].
Deen WM, Bridges CR, Brenner BM. Biophysical basis of glomerular permselectivity. J Membr Biol. 1983;71(1-2):1-10. [Medline].
Dorrington KJ, Tanford C. Molecular size and conformation of immunoglobulins. Adv Immunol. 1970;12:333-81. [Medline].
Massry SG, Glassock RJ. Glomerulonephritis associated with infection. In: Massry SG, Glasscock RJ, eds. Textbook of Nephrology. 3rd ed. Baltimore, Md: Williams & Wilkins; 1995:698-703.
Rodriguez-Iturbe B. Postinfectious glomerulonephritis. Am J Kidney Dis. Jan 2000;35(1):XLVI-XLVIII. [Medline].
Shrier RW, Gottschalk CW, eds. Diseases of the Kidney. Vol 2. 6th ed. Boston, Mass: Little, Brown & Company; 1997:1579- 84.
Silva FG. Acute postinfectious glomerulonephritis and glomerulonephritis complicating persistent bacterial infection. In: Jennette JC, Olson JL, Schwartz MM, eds. Heptinstall's Pathology of the Kidney. Vol 1. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998:389-455.
Wiwanitkit V. Why is acute post-streptococcal glomerulonephritis more common in the pediatric population?. Clin Exp Nephrol. Jun 2006;10(2):164. [Medline].

